
Mindsciences Inc (AKA: Goblue International LLC~Claritas Mindsciences) Profile last edited on: 7/17/2023
CAGE: 6T1X5
UEI: ZUDXNMMM1W21
Business Identifier: Digital therapeutics for behavior change Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Worcester
Congr. District: 02
County: Worcester
Public Profile
In June 2020 it was announced that Mindsciences had been acquired by Sharecare. Earlier in the year (Feb 2020) the two firms has announced a teamed effort offering an evidence based tobacco cessation program. MindSciences merges evidence-based mindfulness, digital technology and neuroscience to create solutions designed - online guidance programs and applications enabling people to control cravings, to overcome addictions, and to change behaviors. The training principles rely on (1) research into how the brain forms habits (2) evidence-based mindfulness practices based on ancient wisdom traditions that date back thousands of years and have been translated for modern-day use through programs such as mindfulness-based stress reduction (MBSR), and (3) new digital delivery mechanisms. Products include Eat Right Now, which includes app based daily exercises, live coaching, and real time feedback to control cravings and eat right food; Unwinding Anxiety, which include lectures and exercises to reduce anxiety in an individual; and Craving To Quit, which is an app based program to enable people to quit smoking over a period of time.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2018 | 1 | NIH | $339,481 | |
Project Title: Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder |
Key People / Management
Judson A Brewer -- President
Mark A Mitchnick -- Chief Executive Officer
Kara Nance -- Senior Medical Advisor
Josh Roman -- Chief Product Officer
Mark A Mitchnick -- Chief Executive Officer
Kara Nance -- Senior Medical Advisor
Josh Roman -- Chief Product Officer